Format
Items per page

Send to:

Choose Destination

Search results

Items: 6

1.

Multiple Myeloma

A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

2.

Smoldering Multiple Myeloma

An asymptomatic and slow-growing PLASMA CELL dyscrasia characterized by presence of MYELOMA PROTEINS and clonal bone marrow plasma cells without end-organ damage (e.g., renal impairment). It is distinguished from MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE by a much higher risk of progression to symptomatic MULTIPLE MYELOMA.

Year introduced: 2018

3.

multiple myeloma M-proteins [Supplementary Concept]

monoclonal proteins secreted in MULTIPLE MYELOMA; don't confuse with from the M-line of skeletal muscle see: myomesin

Date introduced: January 27, 1994

4.

TRAPPC1 protein, human [Supplementary Concept]

RefSeq NM_021210

Date introduced: December 10, 1999

5.

multiple myeloma special antigen-8, human [Supplementary Concept]

associated with multiple myeloma

Date introduced: March 5, 2018

6.

MMSA-1 antigen, human [Supplementary Concept]

Date introduced: September 17, 2017

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Loading ...
Support Center